Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label pilot trial of abatacept in ankylosing spondylitis
2007-002967-28Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Aug 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of abatacept in ankylosing spondylitis (AS) (2 cohorts), sponsored by Charité – Universitätsmedizin Berlin. Started Aug 2007; status: completed.
02
Drugs
abatacept
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on 2007-002967-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002967-28.